Keywords
Palmar erythrodysesthesia
Bleomycin
Doxorubicin
ABVD
How to Cite
Abstract
The ABVD regimen is a first-line treatment for Hodgkin's lymphoma. Skin toxicity is among the most common side effect of this treatment. Two examples are palmoplantar erythrodysesthesia due to doxorubicin and flagellate dermatitis related to bleomycin.
We report a case of palmar erythrodysesthesia and another one of flagellate dermatitis.
References
Webster-Gandy JD, How C, Harrold K. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs. 2007 Jul;11(3):238-46.
Salzmann M, Marmé F, Hassel JC. Prophylaxis and Management of Skin Toxicities. Breast Care (Basel). 2019 Apr;14(2):72-77.
Fernandez-Obregon AC, Hogan KP, Bibro MK. Flagellate pigmentation from intrapleural bleomycin. A light microscopy and electron microscopy study. J Am Acad Dermatol. 1985 Sep;13(3):464-8.
Moulin G, Fière B, Beyvin A. Pigmentation cutanée par la bléomycine. Cutaneous pigmentation caused by bleomycin. Bull Soc Fr Dermatol Syphiligr. 1970;77(2):293-6.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar